LifeStance Health Group, Inc.
LFSTNASDAQHealthcareMedical Care Facilities
As of Oct 16, 2026 close
- Market cap
- $4.79B
- P/E (TTM)
- 94.68
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $4.77$13.56
- Volume (live)
- -
- Avg. volume (3M)
- 4.77M
LifeStance Health Group (LFST) Stock Price & Financial Analysis
LifeStance Health Group Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $11.68 - $12.49 |
|---|---|
| 52-Week High | $13.56 |
| 52-Week Low | $4.77 |
| Open | $12.45 |
| Volume (last close) | 2.82M |
| Average Volume (3M) | 4.77M |
| Revenue (TTM) | 1.58B |
|---|---|
| Net Income (TTM) | 50.60M |
| Free Cash Flow (TTM) | 210.03M |
| EPS (TTM) | $0.13 |
| Profit Margin | 3.19% |
| Operating Margin | 4.95% |
| Return on Equity (ROE) | 3.43% |
| Debt to Equity | 0.14 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 4.79B |
|---|---|
| Shares Outstanding | 387.30M |
| P/E Ratio (TTM) | 94.68 |
| Price to Sales (P/S) | 3.02 |
| Price to Book (P/B) | 3.24 |
| EV/EBITDA | 36.20 |
| 50-Day MA | $12.28 |
|---|---|
| 200-Day MA | $9.01 |
| 1-Year Change | +145.44% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
LifeStance Health Group at a Glance
As of the Oct 16, 2026 close, LifeStance Health Group (LFST) has a market capitalization of $4.79B. The stock trades at 94.7× trailing earnings and 3.0× sales. Over the trailing twelve months it earned $50.60M on revenue of $1.58B (a 3.2% profit margin) and generated $210.03M of free cash flow. Revenue grew 20.4% year over year.
As of its latest reported balance sheet, it holds $225.94M in cash and securities against $200.66M of debt, a net cash position of $25.28M.
LifeStance Health Group does not currently pay a dividend.
The share price is up 145.4% over the past year. At $11.74 (the Oct 16, 2026 close) it sits within its 52-week range of $4.77 to $13.56, above its 200-day moving average of $9.01.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $14.63, 24.6% above the Oct 16, 2026 close.
Frequently Asked Questions About LifeStance Health Group
What is the current stock price for LFST?
As of the Oct 16, 2026 close, LFST stock trades at $11.74. The 52-week range is $4.77–$13.56, with a day range of $11.68–$12.49.
What is the P/E ratio for LFST?
As of the Oct 16, 2026 close, LifeStance Health Group's trailing twelve-month (TTM) P/E ratio is 94.7, meaning investors pay $94.7 for every $1 of annual earnings. LifeStance Health Group operates in the Healthcare sector.
Does LFST pay dividends?
LifeStance Health Group does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for LFST?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for LFST is Buy. The average 12-month price target is $14.63, a 24.6% upside from the Oct 16, 2026 close of $11.74.
What is the market cap of LFST?
As of the Oct 16, 2026 close, LifeStance Health Group's market capitalization is $4.55B, classifying it as a mid-cap company. LifeStance Health Group operates in the Healthcare sector within the Medical Care Facilities industry.